SORORIN and PLK1 as potential therapeutic targets in malignant pleural mesothelioma.
Kato T, Lee D, Wu L, Patel P, Young AJ, Wada H, Hu HP, Ujiie H, Kaji M, Kano S, Matsuge S, Domen H, Kanno H, Hatanaka Y, Hatanaka KC, Kaga K, Matsui Y, Matsuno Y, De Perrot M, Yasufuku K.
Kato T, et al. Among authors: ujiie h.
Int J Oncol. 2016 Dec;49(6):2411-2420. doi: 10.3892/ijo.2016.3765. Epub 2016 Nov 10.
Int J Oncol. 2016.
PMID: 27840913
Free article.